Picture of Pharvaris NV logo

PHVS Pharvaris NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Pharvaris NV expected to post a loss of 53 cents a share - Earnings Preview

* Pharvaris NV  PHVS.OQ   PHVS.O  is expected to show no
change in
quarterly revenue when it reports  results on April 3
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Pharvaris NV is for a
loss
of 53 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pharvaris
NV is
$35.00​, above​ its last closing price of $23.11. ​​​

Previous quarterly performance (using preferred earnings measure
in euros). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.59       -0.60      -0.58     Beat    3.4
 Jun. 30 2023  -0.59       -0.65      -0.63     Beat    3.1
 Mar. 31 2023  -0.74       -0.74      -0.67     Beat    9.9​
 Dec. 31 2022  -0.68       -0.65      -1.17     Missed  -79.4
 ​​Sep.        -0.63       -0.63      -0.25     Beat    60.5
 30 2022                                                
 Jun. 30 2022  -0.57       -0.56      -0.38     Beat    31.8​
 Mar. 31 2022  -0.43       -0.49      -0.48     Beat    2.7
 Dec. 31 2021  -0.99       -0.71      -0.09     Beat    87.3
 This summary was machine generated April 1 at 10:55 GMT.  All
figures in euros unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Pharvaris NV

See all news